首页> 美国卫生研究院文献>Turkish Journal of Obstetrics and Gynecology >The efficacy of Ankaferd Blood Stopper® in an experimental Asherman syndrome model created in rats
【2h】

The efficacy of Ankaferd Blood Stopper® in an experimental Asherman syndrome model created in rats

机译:Ankaferd BloodStopper®在大鼠实验性Asherman综合征模型中的功效

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Objective:Asherman syndrome (AS) is a progressive disease involving menstrual disorders, recurrent pregnancy losses, and infertility developing as a result of partial or full blockade of the uterine cavity with adhesions. AS generally develops after trauma to the basal layer of the endometrium. In spite of a variety of methods such as adhesiolysis, inserting intrauterine devices, and administering high doses of estrogen, treatments remain insufficient. This study aimed to assess the effects of local intrauterine Ankaferd Blood Stopper (ABS) administration in inducing endometrial proliferation and building a normal endometrial layer in a rat model.
机译:目的:阿舍曼综合症(ASher)是一种进展性疾病,涉及月经失调,反复流产和由于部分或完全阻塞子宫腔粘连而导致的不育症。 AS通常在子宫内膜基底层受损伤后发展。尽管有多种方法,例如粘连溶解,插入宫内节育器和施用高剂量的雌激素,治疗仍然不足。这项研究旨在评估局部子宫内Ankaferd止血剂(ABS)给药在诱导大鼠子宫内膜增生和建立正常子宫内膜层中的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号